Back to search

Article

Image-Guided Mesenchymal Stem Cell Sodium Iodide Symporter (NIS) Radionucleotide Therapy for Glioblastoma

2024-07-09

Abstract excerpt

<h4>Background: </h4> Glioblastoma (GBM) is a highly aggressive, invasive, and growth-factor-independent grade IV glioma. Survival following the diagnosis is generally poor, with a median survival of approximately 15 months, and it is considered the most aggressive and lethal central nervous system tumor. Conventional treatments based on surgery, chemotherapy, and radiation therapy only delay progression, and deat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6e5f2cf0-c79a-5dcd-a6ab-169a2d86b5a6
DOI
10.20944/preprints202407.0690.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Image-Guided Mesenchymal Stem Cell Sodium Iodide Symporter (NIS) Radionucleotide Therapy for GlioblastomaDOI 10.20944/preprints202407.0690.v1
Select a neighboring publication to make it the new centre.